For research use only. PeptaBase is for informational and laboratory research reference only. No medical claims are made and nothing on this site is intended to diagnose, treat, cure or prevent any disease.
PeptaBase
500+ PubMed CitationsFree To UseNo Account Required
Back to Database
Metabolic

Mazdutide Protocol

Dosing & Research

Last Updated: September 4, 2026

Chemical Identity
Molecular Formula
C210H322N46O67
Molecular Weight
4563.06 g/mol
CAS Number
2259884-03-0

Obesity and diabetes trials, GLP-1/glucagon dual-agonist pharmacology, Weight-loss research, NAFLD/metabolic disease studies

Half-Life
Long-acting; roughly supports once-weekly dosing
Administration
Subcutaneous
Frequency
Once Weekly, Same Day Each Week

How It Works

  • Obesity and diabetes trials
  • GLP-1/glucagon dual-agonist pharmacology
  • Weight-loss research
  • NAFLD/metabolic disease studies

Dosing Structure

Dose
1-6mg weekly (titrated)
Frequency
Once Weekly, Same Day Each Week
Notes
Starting dose: 1-2mg once weekly. Escalation: Gradual increase over 4-8 weeks. Target dose: 3-6mg once weekly. Titration: Week 1-4: 1-2mg | Week 5-8: 2-3mg | Week 9-12: 3-4mg | Week 13+: up to 6mg based on response and tolerance. No need to increase dose if experiencing benefits. Inject: Abdomen, thigh, or upper arm (rotate). Medical supervision required.

Example Protocols

Dose: 1-6mg weekly (titrated)
Frequency: Once Weekly, Same Day Each Week
Duration: 12-24 weeks; reassess monthly
Off Period: Not listed
Calculate dosing →

Find Research Grade Mazdutide

Recommended vendors for sourcing research-grade material. PeptaBase does not sell peptides directly.

Vendor One Research Labs

COA Verified

Third-party COA-verified research peptides with published batch testing.

Source Coming Soon

Vendor Two Sciences

Purity Tested

US-based research compound supplier with independent purity testing.

Source Coming Soon

Vendor Three Peptide Co.

Bulk research peptide sourcing with batch-level documentation.

Source Coming Soon
View all recommended vendors →

Protocol Notes

Starting dose: 1-2mg once weekly.
Escalation: Gradual increase over 4-8 weeks.
Target dose: 3-6mg once weekly.
Titration
Week 1-4: 1-2mgWeek 5-8: 2-3mgWeek 9-12: 3-4mgWeek 13+: up to 6mg based on response and tolerance
No need to increase dose if experiencing benefits.
Inject: Abdomen, thigh, or upper arm (rotate).
Medical supervision required.

Research & Studies

Loading citations…

    Research Feedback

    0 approved

    For research discussion only. Community feedback is moderated and shown here as aggregated insights after approval.

    Related Peptides

    5 Amino 1 MQ
    Metabolic
    AICAR
    Metabolic
    AOD-9604
    Metabolic
    Cagrilintide
    Metabolic